ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.

ResMed RMD has achieved impressive growth over the past year, with its shares rallying 25.6%. It has outperformed the industry’s 13.1% rise and the S&P 500 composite’s 15.7% gain. Presently carrying a ...

Today, Resmed is taking the next step – transforming into a fully ... treatment for sleep apnea “Resmed has evolved beyond its origins as a CPAP device and mask manufacturer. Our new brand reflects ...

ResMed Inc.’s RMD growth in the second quarter of fiscal 2025 can be attributed to the robust performance of its Mask business. Its Device sales continue to drive overall revenue growth. The company’s ...

The quarter saw ResMed continue its strategic expansion with significant investments in innovation, including the launch of new products like the AirTouch N30i mask, designed to enhance patient ...

Resmed, a leader in health technology focused ... apnea “Resmed has evolved beyond its origins as a CPAP device and mask manufacturer. Our new brand reflects who we are today – a global ...

ResMed's significant 11% year-over-year revenue growth was primarily propelled by innovations and strong demand for its sleep devices and masks. The gross margin boost was aided by manufacturing ...

ResMed's second-quarter revenue rose 10% to $1.28 billion, driven by increased demand for its sleep devices and the masks portfolio. Analysts on average had expected quarterly revenue of $1.27 ...

ResMed Inc.’s RMD growth in the second quarter of fiscal 2025 can be attributed to the robust performance of its Mask business. Its Device sales continue to drive overall revenue growth.